Ensitrelvir is being evaluated for the treatment of COVID-19 to be administered as an oral tablet formulation taken once daily for five days.
Construction is now underway with the facility scheduled to be operational by 2025
Sause will become CEO Roche Diagnostics and a member of the Corporate Executive Committee effective 1 January 2023.
Juan Andres Appointed to President, Strategic Partnerships and Enterprise Expansion
Mandaviya felicitated voluntary blood donors and states/UTs that have done exemplary work
The proposed acquisition consideration represents an equity value for Myovant of $2.4 billion and an enterprise value of $2.5 billion.
Ours is a story of India’s resilient public health system and of everyone working together as team India to battle the pandemic
Department and Industry Associations to organize 3 days National Level Expo on Indian Medical Devices Sector at Pragati Maidan, New Delhi between 9-11 Dec 2022, first of its kind expo in India
Subscribe To Our Newsletter & Stay Updated